Stay informed with the latest litigation news. Explore now

IP Verse

Ventana Medical Systems competitive analysis

Latest publications and patents of Ventana Medical Systems New

Explore the latest publications and patents granted to Ventana Medical Systems, showcasing their recent innovations and technological advancements.

Last updated on: Sep 3, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ventana Medical Systems

EP3111221
Jan 19, 2022Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3Patent Maintained As Amended
EP3149481
Jan 9, 2019Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1Revoked
EP2356460
Jan 24, 2018Method For Prediction Of The Progression Risk Of TumorsNo Opposition Filed Within Time Limit
EP2898329
May 17, 2017Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A MarkerOpposition Rejected

Latest patents of Ventana Medical Systems opposed by its competitors

Explore Ventana Medical Systems's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3111221
Jan 19, 2022Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp31
EP3149481
Jan 9, 2019Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L11
EP2898329
May 17, 2017Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker1

Latest PTAB cases involving Ventana Medical Systems New

Discover the latest PTAB cases involving Ventana Medical Systems, highlighting their recent legal challenges and patent disputes.

Top competitors of Ventana Medical Systems

Top competitors of Ventana Medical Systems based on patent oppositions.